🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00373958
Treatments Being Tested
The purpose of this study is to evaluate the safety of administering a comb...
Status
Completed
Location
UCLA Center For Vaccine Research
Start Date
2005-12
Trial ID
NCT00133445
Treatments Being Tested
The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00345579
The objective for this study is to characterize the safety profile of PENTA...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00804284
Treatments Being Tested
The purpose of the study is to characterize the immunogenicity \& safety of...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-02-13
Trial ID
NCT00614614
The purpose of this study is to evaluate the safety and immunogenicity of B...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-27
Trial ID
NCT03621670
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
The purpose of this study is to evaluate the safety, reactogenicity and imm...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-01
Trial ID
NCT01978093
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335